Gastrointestinal Oncology
Metastatic colorectal cancer is a key area of interest, with trials centered on treatment response and disease control in advanced colorectal malignancy.
- Objective response in advanced colorectal cancer
- Tumour control and progression management
- Systemic therapy for metastatic disease
Research activity in this field reflects a focus on therapeutic strategies for patients with disseminated gastrointestinal cancer.
Genitourinary Oncology
Clinical research includes metastatic urothelial cancer and unfavorable intermediate/high-risk prostate cancer, addressing both advanced urinary tract malignancy and localized high-risk prostate cancer.
- Metastatic urothelial carcinoma
- High-risk prostate cancer management
- Disease control and survival outcomes
The sponsor’s portfolio spans treatment approaches for aggressive genitourinary cancers with distinct clinical needs.
Autoimmune Skin Disorders
Vitiligo, including non-segmental vitiligo, is another major therapeutic area, with studies evaluating repigmentation-oriented treatment strategies in adult patients.
- Non-segmental vitiligo
- Active depigmentation disorders
- Skin repigmentation therapies
Research in this domain focuses on autoimmune dermatology and clinical approaches for pigment restoration.
Phototherapy-Based Dermatologic Treatment
Trials also examine combined approaches involving narrowband UVB phototherapy and PPARγ-selective activation, with interest in pioglitazone as part of treatment for pigmentary skin disease.
- Phototherapy for vitiligo
- PPARγ-targeted dermatologic therapy
- Pioglitazone in skin disease
This area links dermatology with targeted modulation of pathways relevant to melanocyte function and skin repigmentation.
